Takeda Pharmaceutical Co Ltd ADR (TAK) — Capital Reinvestment Ratio
Latest as of December 2025:
0.12x
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow ($360.04 Billion) in capital expenditures ($42.57 Billion). See Takeda Pharmaceutical Co Ltd ADR (TAK) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.12x
Capex / Operating Cash Flow
Operating Cash Flow
$360.04 Billion
USD
Capital Expenditures
$42.57 Billion
USD
Data as of
Dec 2025
Most recent filing
Takeda Pharmaceutical Co Ltd ADR Capital Reinvestment Ratio (2000–2025)
This chart tracks Takeda Pharmaceutical Co Ltd ADR's Capital Reinvestment Ratio across 26 annual periods.
Annual Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. For live market cap and broader valuation context, see TAK company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $1.06 Trillion | $200.79 Billion | ▼ -71.7% |
| 2024 | 0.67x | $716.34 Billion | $480.73 Billion | ▲ +3.5% |
| 2023 | 0.65x | $977.16 Billion | $633.69 Billion | ▲ +291.5% |
| 2022 | 0.17x | $1.12 Trillion | $186.04 Billion | ▼ -29.2% |
| 2021 | 0.23x | $1.01 Trillion | $236.47 Billion | ▼ -28.0% |
| 2020 | 0.33x | $669.75 Billion | $217.71 Billion | ▼ -20.4% |
| 2019 | 0.41x | $328.48 Billion | $134.11 Billion | ▲ +20.3% |
| 2018 | 0.34x | $377.85 Billion | $128.26 Billion | ▼ -20.8% |
| 2017 | 0.43x | $261.36 Billion | $112.03 Billion | ▼ -87.1% |
| 2016 | 3.33x | $25.49 Billion | $84.86 Billion | ▲ +458.9% |
| 2015 | 0.60x | $182.52 Billion | $108.72 Billion | ▲ +12.5% |
| 2014 | 0.53x | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $158.96 Billion | $35.42 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow